Fred Hutchinson Research Center leads immunotherapy trials

Thursday, April 7, 2011 11:11 AM

The National Cancer Institute has selected 27 sites to participate in a clinical trials network led by the Fred Hutchinson Cancer Research Center to study new cancer drugs, according to the Puget Sound Business Journal.

The Fred Hutchinson Cancer Research Center was awarded a $17 million grant by the National Cancer Institute to lead the cancer immunotherapy trials network that will examine immunotherapy drug candidates. Clinical trial sites will be spread out across the U.S. and Canada.

Immunotherapies are a new field in cancer drugs that train the body’s defense system to attack cancer cells or prevent them from forming. The cancer immunotherapy trials network is expected to start trials in early 2012.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs